Use of an Electronic Clinical Decision Support System in Primary Care to Assess Inappropriate Polypharmacy in Young Seniors With Multimorbidity: Observational, Descriptive, Cross-Sectional Study

Eloisa Rogero-Blanco, Juan A Lopez-Rodriguez, Teresa Sanz-Cuesta, Mercedes Aza-Pascual-Salcedo, M Jose Bujalance-Zafra, Isabel Cura-Gonzalez, MultiPAP Group, Eloisa Rogero-Blanco, Juan A Lopez-Rodriguez, Teresa Sanz-Cuesta, Mercedes Aza-Pascual-Salcedo, M Jose Bujalance-Zafra, Isabel Cura-Gonzalez, MultiPAP Group

Abstract

Background: Multimorbidity is a global health problem that is usually associated with polypharmacy, which increases the risk of potentially inappropriate prescribing (PIP). PIP entails higher hospitalization rates and mortality and increased usage of services provided by the health system. Tools exist to improve prescription practices and decrease PIP, including screening tools and explicit criteria that can be applied in an automated manner.

Objective: This study aimed to describe the prevalence of PIP in primary care consultations among patients aged 65-75 years with multimorbidity and polypharmacy, detected by an electronic clinical decision support system (ECDSS) following the 2015 American Geriatrics Society Beers Criteria, the European Screening Tool of Older Person's Prescription (STOPP), and the Screening Tool to Alert doctors to Right Treatment (START).

Methods: This was an observational, descriptive, cross-sectional study. The sample included 593 community-dwelling adults aged 65-75 years (henceforth called young seniors), with multimorbidity (≥3 diseases) and polypharmacy (≥5 medications), who had visited their primary care doctor at least once over the last year at 1 of the 38 health care centers participating in the Multimorbidity and Polypharmacy in Primary Care (Multi-PAP) trial. Sociodemographic data, clinical and pharmacological treatment variables, and PIP, as detected by 1 ECDSS, were recorded. A multivariate logistic regression model with robust estimators was built to assess the factors affecting PIP according to the STOPP criteria.

Results: PIP was detected in 57.0% (338/593; 95% CI 53-61) and 72.8% (432/593; 95% CI 69.3-76.4) of the patients according to the STOPP criteria and the Beers Criteria, respectively, whereas 42.8% (254/593; 95% CI 38.9-46.8) of the patients partially met the START criteria. The most frequently detected PIPs were benzodiazepines (BZD) intake for more than 4 weeks (217/593, 36.6%) using the STOPP version 2 and the prolonged use of proton pump inhibitors (269/593, 45.4%) using the 2015 Beers Criteria. Being a woman (odds ratio [OR] 1.43, 95% CI 1.01-2.01; P=.04), taking a greater number of medicines (OR 1.25, 95% CI 1.14-1.37; P<.04), working in the primary sector (OR 1.91, 95% CI 1.25-2.93; P=.003), and being prescribed drugs for the central nervous system (OR 3.75, 95% CI 2.45-5.76; P<.001) were related to a higher frequency of PIP.

Conclusions: There is a high prevalence of PIP in primary care as detected by an ECDSS in community-dwelling young seniors with comorbidity and polypharmacy. The specific PIP criteria defined by this study are consistent with the current literature. This ECDSS can be useful for supervising prescriptions in primary health care consultations.

Keywords: clinical decision support systems; multimorbidity; polypharmacy; potentially inappropriate medication list; primary care.

Conflict of interest statement

Conflicts of Interest: None declared.

©Eloisa A Rogero-Blanco, Juan A Lopez-Rodriguez, Teresa Sanz-Cuesta, Mercedes Aza-Pascual-Salcedo, M Jose Bujalance-Zafra, Isabel Cura-Gonzalez, MultiPAP Group. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 03.03.2020.

References

    1. World Health Organization 2008. The World Health Report 2008 - primary Health Care (Now More Than Ever)
    1. The Academy of Medical Sciences. 2018. Apr, Multimorbidity: a priority for global health research .
    1. Rankin A, Cadogan CA, Patterson SM, Kerse N, Cardwell CR, Bradley MC, Ryan C, Hughes C. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018 Dec 03;9:CD008165. doi: 10.1002/14651858.CD008165.pub4.
    1. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991 Sep;151(9):1825–32.
    1. Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999-2012. J Am Med Assoc. 2015 Nov 03;314(17):1818–31. doi: 10.1001/jama.2015.13766.
    1. Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med. 2015 Apr 07;13:74. doi: 10.1186/s12916-015-0322-7.
    1. Molina López T, Caraballo Camacho MD, Palma Morgado D, López Rubio S, Domínguez Camacho JC, Morales Serna JC. [Prevalence of multiple medication and cardiovascular risk in patients over 65 years] Aten Primaria. 2012 Apr;44(4):216–22. doi: 10.1016/j.aprim.2011.03.010.
    1. Gavilán Moral E, Morales Suárez-Varela MT, Hoyos Esteban JA, Pérez Suanes AM. Polimedicación y prescripción de fármacos inadecuados en pacientes ancianos inmovilizados que viven en la comunidad. Atención Primaria. 2006 Nov;38(9):476–480. doi: 10.1157/13095047.
    1. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol. 2010 May;69(5):543–52. doi: 10.1111/j.1365-2125.2010.03628.x. doi: 10.1111/j.1365-2125.2010.03628.x.
    1. Cruz-Esteve I, Marsal-Mora JR, Galindo-Ortego G, Galván-Santiago L, Serrano-Godoy M, Ribes-Murillo E, Real-Gatius J, en representación del grupo de investigación GRETAP [Potentially inappropriate prescribing in older Spanish population according to STOPP/START criteria (STARTREC study)] Aten Primaria. 2017 Mar;49(3):166–176. doi: 10.1016/j.aprim.2016.02.013.
    1. Blanco-Reina E, García-Merino MR, Ocaña-Riola R, Aguilar-Cano L, Valdellós J, Bellido-Estévez I, Ariza-Zafra G. Assessing potentially inappropriate prescribing in community-dwelling older patients using the updated version of STOPP-START criteria: a comparison of profiles and prevalences with respect to the original version. PLoS One. 2016;11(12):e0167586. doi: 10.1371/journal.pone.0167586.
    1. Pérez T, Moriarty F, Wallace E, McDowell R, Redmond P, Fahey T. Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study. Br Med J. 2018 Dec 14;363:k4524. doi: 10.1136/bmj.k4524.
    1. Moriarty F, Bennett K, Cahir C, Kenny RA, Fahey T. Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community-dwelling older people: a prospective cohort study. Br J Clin Pharmacol. 2016 Dec;82(3):849–57. doi: 10.1111/bcp.12995. doi: 10.1111/bcp.12995.
    1. Leelakanok N, Holcombe AL, Lund BC, Gu X, Schweizer ML. Association between polypharmacy and death: a systematic review and meta-analysis. J Am Pharm Assoc (2003) 2017;57(6):729–738.e10. doi: 10.1016/j.japh.2017.06.002.
    1. Hill-Taylor B, Sketris I, Hayden J, Byrne S, O'Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013 Oct;38(5):360–72. doi: 10.1111/jcpt.12059.
    1. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen HJ, Feussner JR. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992 Oct;45(10):1045–51.
    1. Motter FR, Fritzen JS, Hilmer SN, Paniz ÉV, Paniz VM. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol. 2018 Jun;74(6):679–700. doi: 10.1007/s00228-018-2446-0.
    1. Delgado Silveira E, Montero Errasquín B, Muñoz García M, Vélez-Díaz-Pallarés M, Lozano Montoya I, Sánchez-Castellano C, Cruz-Jentoft AJ. [Improving drug prescribing in the elderly: a new edition of STOPP/START criteria] Rev Esp Geriatr Gerontol. 2015;50(2):89–96. doi: 10.1016/j.regg.2014.10.005.
    1. American Geriatrics Society 2015 Beers Criteria Update Expert Panel American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015 Nov;63(11):2227–46. doi: 10.1111/jgs.13702.
    1. Hill-Taylor B, Walsh KA, Stewart S, Hayden J, Byrne S, Sketris IS. Effectiveness of the STOPP/START (Screening Tool of Older Persons' potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther. 2016 Apr;41(2):158–69. doi: 10.1111/jcpt.12372.
    1. Reis W, Bonetti A, Bottacin W, Reis A, Souza T, Pontarolo R, Correr C, Fernandez-Llimos F. Impact on process results of clinical decision support systems (CDSSs) applied to medication use: overview of systematic reviews. Pharm Pract (Granada) 2017;15(4):1036. doi: 10.18549/PharmPract.2017.04.1036.
    1. Clyne B, Bradley MC, Hughes C, Fahey T, Lapane KL. Electronic prescribing and other forms of technology to reduce inappropriate medication use and polypharmacy in older people: a review of current evidence. Clin Geriatr Med. 2012 May;28(2):301–22. doi: 10.1016/j.cger.2012.01.009.
    1. Soiza RL, Subbarayan S, Antonio C, Cruz-Jentoft AJ, Petrovic M, Gudmundsson A, O'Mahony D. The SENATOR project: developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy. Ther Adv Drug Saf. 2017 Mar;8(3):81–85. doi: 10.1177/2042098616675851.
    1. Sönnichsen A, Trampisch US, Rieckert A, Piccoliori G, Vögele A, Flamm M, Johansson T, Esmail A, Reeves D, Löffler C, Höck J, Klaassen-Mielke R, Trampisch HJ, Kunnamo I. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial. Trials. 2016 Jan 29;17:57. doi: 10.1186/s13063-016-1177-8.
    1. Christiane M. U.S National Library of Medicine. 2018. [2020-01-13]. Application for an Electronic Medication Management Support System (AdAM) .
    1. Stefanie HM. U.S National Library of Medicine. OPtimising thERapy to Prevent Avoidable Hospital Admissions in the Multimorbid Older People (OPERAM) Internet .
    1. Young A, Tordoff J, Dovey S, Reith D, Lloyd H, Tilyard M, Smith A. Using an electronic decision support tool to reduce inappropriate polypharmacy and optimize medicines: rationale and methods. JMIR Res Protoc. 2016 Jun 10;5(2):e105. doi: 10.2196/resprot.5543.
    1. Barris Blundell D. Revisión de medicación según criterios STOPP/START en pacientes mayores del servicio de sistema personalizado de dosificación de medicamentos de una farmacia comunitaria. Farm Comunitarios. 2015 Jun 01;7(2):31–36. doi: 10.5672/FC.2173-9218.(2015/Vol7).002.05.
    1. González-Rojano E, Acosta SV, Palacián DR, Hernández M, Abad-Santos F. Utility of Checkthemeds® for detection of potentially inappropriate medication in hospitalized patients. Clin Ther. 2017 Aug;39(8):e37. doi: 10.1016/j.clinthera.2017.05.116.
    1. Prados-Torres A, Del Cura-González I, Prados-Torres D, López-Rodríguez JA, Leiva-Fernández F, Calderón-Larrañaga A, López-Verde F, Gimeno-Feliu LA, Escortell-Mayor E, Pico-Soler V, Sanz-Cuesta T, Bujalance-Zafra MJ, Morey-Montalvo M, Boxó-Cifuentes JR, Poblador-Plou B, Fernández-Arquero JM, González-Rubio F, Ramiro-González MD, Coscollar-Santaliestra C, Martín-Fernández J, Barnestein-Fonseca MP, Valderas-Martínez JM, Marengoni A, Muth C, Multi-PAP Group Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project) Implement Sci. 2017 Apr 27;12(1):54. doi: 10.1186/s13012-017-0584-x.
    1. Domingo-Salvany A, Bacigalupe A, Carrasco JM, Espelt A, Ferrando J, Borrell C, del Grupo de Determinantes Sociales de Sociedad Española de Epidemiología [Proposals for social class classification based on the Spanish National Classification of Occupations 2011 using neo-Weberian and neo-Marxist approaches] Gac Sanit. 2013;27(3):263–72. doi: 10.1016/j.gaceta.2012.12.009.
    1. O'Halloran J, Miller G, Britt H. Defining chronic conditions for primary care with ICPC-2. Fam Pract. 2004 Aug;21(4):381–6. doi: 10.1093/fampra/cmh407.
    1. O Riordan D, Aubert CE, Walsh KA, Van Dorland A, Rodondi N, Du Puy RS, Poortvliet RK, Gussekloo J, Sinnott C, Byrne S, Galvin R, Jukema JW, Mooijaart SP, Baumgartner C, McCarthy V, Walsh EK, Collet T, Dekkers OM, Blum MR, Kearney PM. Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study. BMJ Open. 2018 Mar 22;8(3):e019003. doi: 10.1136/bmjopen-2017-019003.
    1. Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015 Dec;71(12):1415–27. doi: 10.1007/s00228-015-1954-4.
    1. Zhang X, Zhou S, Pan K, Li X, Zhao X, Zhou Y, Cui Y, Liu X. Potentially inappropriate medications in hospitalized older patients: a cross-sectional study using the Beers 2015 criteria versus the 2012 criteria. Clin Interv Aging. 2017;12:1697–1703. doi: 10.2147/CIA.S146009. doi: 10.2147/CIA.S146009.
    1. Kim GJ, Lee KH, Kim JH. South Korean geriatrics on Beers Criteria medications at risk of adverse drug events. PLoS One. 2018;13(3):e0191376. doi: 10.1371/journal.pone.0191376.
    1. Blanco-Reina E, Ariza-Zafra G, Ocaña-Riola R, León-Ortiz M. 2012 American Geriatrics Society Beers criteria: enhanced applicability for detecting potentially inappropriate medications in European older adults? A comparison with the Screening Tool of Older Person's Potentially Inappropriate Prescriptions. J Am Geriatr Soc. 2014 Jul;62(7):1217–23. doi: 10.1111/jgs.12891.
    1. Lucchetti G, Lucchetti AL. Inappropriate prescribing in older persons: a systematic review of medications available in different criteria. Arch Gerontol Geriatr. 2017;68:55–61. doi: 10.1016/j.archger.2016.09.003.
    1. Pastor Cano J, Aranda García A, Gascón Cánovas JJ, Rausell Rausell VJ, Tobaruela Soto M. [Beers versus STOPP criteria and the possible implications of the Beers criteria's Spanish adaptation] Farm Hosp. 2017 Jan 01;41(n01):130–131. doi: 10.7399/fh.2017.41.1.10568. doi: 10.7399/fh.2017.41.1.10568.
    1. Meulendijk MC, Spruit MR, Drenth-van MA, Numans ME, Brinkkemper S, Jansen PA, Knol W. Computerized decision support improves medication review effectiveness: an experiment evaluating the STRIP assistant's usability. Drugs Aging. 2015 Jun;32(6):495–503. doi: 10.1007/s40266-015-0270-0.
    1. Niehoff KM, Rajeevan N, Charpentier PA, Miller PL, Goldstein MK, Fried TR. Development of the tool to reduce inappropriate medications (TRIM): a clinical decision support system to improve medication prescribing for older adults. Pharmacotherapy. 2016 May 28;36(6):694–701. doi: 10.1002/phar.1751.
    1. Nauta KJ, Groenhof F, Schuling J, Hugtenburg JG, van Hout HP, Haaijer-Ruskamp FM, Denig P. Application of the STOPP/START criteria to a medical record database. Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1242–1247. doi: 10.1002/pds.4283.
    1. Anrys P, Boland B, Degryse J, De Lepeleire J, Petrovic M, Marien S, Dalleur O, Strauven G, Foulon V, Spinewine A. STOPP/START version 2-development of software applications: easier said than done? Age Ageing. 2016 Sep;45(5):589–92. doi: 10.1093/ageing/afw114.
    1. Price M, Davies I, Rusk R, Lesperance M, Weber J. Applying STOPP guidelines in primary care through electronic medical record decision support: randomized control trial highlighting the importance of data quality. JMIR Med Inform. 2017 Jun 15;5(2):e15. doi: 10.2196/medinform.6226.

Source: PubMed

3
Abonneren